Comparison of three genotyping methods for the detection of HIV-1 resistance to antiretroviral drugs;Comparación de tres métodos genotípicos para la detección de resistencia del VIH-1 a los antirretrovirales

Revista Espanola de Quimioterapia

Volumn 15, Issue 1, 2002, Pages 43-48

  Suarez A ^a   Picazo, J ^a   Alonso, R ^a   Bouza, E ^a   Delgado, R ^a   Rodriguez Noriega A ^a   Bernal, A ^a   Garcia A ^a  

^a HOSPITAL CLÍNICO SAN CARLOS   (Spain)

Author keywords

Drug resistance; HIV; Mutations

Indexed keywords

ANTIRETROVIRUS AGENT; PROTEINASE; RNA DIRECTED DNA POLYMERASE; VIRUS PROTEIN; ANTI HUMAN IMMUNODEFICIENCY VIRUS AGENT;

ARTICLE; CODON; DNA SEQUENCE; DRUG ACTIVITY; DRUG RESISTANCE; GENOTYPE; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HYBRIDIZATION; INTERMETHOD COMPARISON; LIFE EXPECTANCY; MULTIDRUG RESISTANCE; SENSITIVITY AND SPECIFICITY; SEQUENCE ANALYSIS; TREATMENT FAILURE; VIRUS MUTANT; VIRUS MUTATION; ANTIBIOTIC RESISTANCE; COMPARATIVE STUDY; DRUG EFFECT; GENETICS; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; MUTATION;

ANTI-HIV AGENTS; DRUG RESISTANCE, VIRAL; GENOTYPE; HIV-1; HUMANS; MUTATION;

EID: 0036274508     PISSN: 02143429     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (24)

1. Importance ofprotease inhibitor plasma levels in HIV-infected patients treated with genotypic-guided therapy: Pharmacological data from the Viradapt study
2. Randomisez, controled phase I/II, trial of combination therapy with delavirdine (U-90152S) and conventional nucleosides in human immunodeficiency virus type I-infected patients
3. Transmision of HIV-1 resistant to nevirapine and zidovudine
4. Public health implications of antiretroviral therapy and HIV drug resistance
5. Antiretroviral drug resistance testing in adults with HIV infection: Implications for clinical management
6. Nucleoside reverse transcriptase inhibitors and resistance of HIV-1
7. Antiretroviral drug resistance testing in adults HIV-1 infection
8. Análisis comparativo de los métodos de detección de resistencias
9. Drug-resistance genotyping in HIV-1 therapy: The VIRADAPT randomised controled trial
10. Clinical utility of testing HIV for drug resistance
11. Achieving longer high-accuracy reads on the ABI PRISM 377 sequencer
12. Line probe assay for rapid detection of drug-selected mutations in the human immunodeficiency virus type I reverse transcriptase gene
13. Comparison of the LiPA HIV-1 RT test, selective PCR and direct solid phase sequencing for the detection of HIV-1 drug resistance mutations
14. Mutations in retroviral genes associated with drug resistance
15. Analysis of HIV1 mutation patterns failing antiretroviral therapy
16. Patterns of resistance mutations to antiretroviral drugs in extensively tretaed HIV-1-infected patients with failure of highly active antiretroviral therapy
17. Comparative performance of high-density oligonucleotide sequencing and dideoxynucleotide sequencing of HIV type 1 pol from clinical samples
18. Comparison of line probe assay (LIPA) and sequence analysis for detection of HIV-1 drug resistance
19. Line probe assay for detection of human immunodeficiency virus type I mutations conferring resistance to nucleoside inhibitors of reverse transcriptase: Comparison with sequence analysis
20. Recovery and analysis of human immunodeficiency virus type 1 (HIV) RNA sequences from plasma samples with low HIV RNA levels
21. Comparative evaluation of three immunodeficiency virus genotyping systems: The HIV-genotyp® method, the HIV PRT GeneChip assay, and the HIV-1 RT line probe assay
22. Genetic polymorphism near HIV-1 reverse transcriptase resistance-associated codons is major obstacle for the line probe assay as an alternative method to sequence analysis
23. Comparison of DNA sequencing and a line probe assay for detection of human immunodeficiency virus type I drug resistance mutations in patients failing highly active antiretroviral therapy